Christina Eliasson is an accomplished professional with extensive experience in the pharmaceutical and healthcare sectors, currently serving as the Commercial Lead for the Chiesi CARE portfolio in the Nordics at Chiesi Nordic since August 2022. Christina has held various leadership roles, including Marketing Lead for asthma and COPD in Sweden, and Nordic Brand Manager (consultant) in respiratory care. Prior to Chiesi, Christina worked at Sobi as Global Brand Lead for ELOCTA and Global Product Manager in haemophilia, as well as at Janssen Inc. in positions that included Nordic Brand Manager and Business Team Lead for HIV and Prostate Cancer. With a strong background in marketing, strategic planning, and cross-functional team leadership, Christina has cultivated skills across multiple therapeutic areas. Christina's educational qualifications include an MSc in Advanced Neuro- and Molecular Pharmacology from the University of Bristol and various courses in pharma marketing and communication.
This person is not in any teams
Chiesi Nordic
1 followers
Chiesi is an international, privately-owned pharmaceutical company with its Corporate Head Office based in Parma, Italy. Chiesi is dedicated to the research, development and sales of innovative, therapeutic prescription medicines in the fields of respiratory, neonatology, transplant medicine and rare diseases. Founded in 1935, as a family firm, today, Chiesi spans the globe, employing more than 5000 people in 26 affiliates worldwide and distributes its products in more than 70 countries. In the Nordics, Chiesi Pharma AB employs more than 50 dedicated employees, who are based out of our head office in Central Stockholm, the recently integrated Research and Development Centre at Lidingö outside Stockholm or are part of our experienced field-based sales teams. As with every part of the Chiesi group, we embrace a shared set of values and a common code of ethical conduct. This demands the highest standards of reliability, transparency, and individual accountability in everything we do. It emphasizes the importance of collaborative working, putting people first and exchanging knowledge. Implicit in all of these values is a responsible attitude to the social and environmental impact of our actions. Chiesi is entering important new therapy areas, such as organ transplantation and rare diseases, alongside our treatments for respiratory conditions.